During a Thursday press conference in the Oval Office, a man collapsed behind President Donald Trump at an event focused on expanding coverage and reducing prices for obesity treatments Zepbound and Wegovy.
Officials quickly came to his aid, with Dr. Mehmet Oz, Administrator of the Centers for Medicare and Medicaid Services, supporting the man’s head as he was lowered to the floor. The press was swiftly escorted out of the room. The cause of the collapse remained unclear.
White House press secretary Karoline Leavitt informed reporters the individual was a guest of the attending health care companies Eli Lilly and Novo Nordisk. She stated:
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
About an hour later, President Trump resumed the event. The man did not return to the Oval Office gathering, but Trump commented that the gentleman had felt lightheaded and was now fine.
President Trump announced an agreement with drugmakers Eli Lilly and Novo Nordisk to broaden Medicare coverage and lower costs for the widely used obesity medications Zepbound and Wegovy.
The man’s sudden collapse briefly interrupted the event, but quick medical response ensured his well-being, allowing President Trump to continue highlighting key health policy progress.